Human herpesvirus 8 presence and viral load are associated with the progression of AIDS-associated Kaposi's sarcoma
- PMID: 17630548
- DOI: 10.1097/QAD.0b013e3282202b7d
Human herpesvirus 8 presence and viral load are associated with the progression of AIDS-associated Kaposi's sarcoma
Abstract
Objective: We present the largest longitudinal study to date that examines the association between Kaposi's Sarcoma (KS) disease progression and the presence and viral load of human herpesvirus 8 (HHV-8).
Methods: Ninety-six men were enrolled at HIV clinics in Atlanta, Georgia, who had KS (n = 47) or were without KS but seropositive for HHV-8. Visits occurred at 6-month intervals for 2 years at which the patient's KS status was evaluated and oral fluid and blood were collected for quantification of HHV-8 DNA and antibodies.
Results: The presence of HHV-8 DNA in blood was more common (P < 0.001) and the viral load higher (P < 0.001) in men with KS in comparison with men without KS. Mean HHV-8 viral loads in blood and oral fluids were associated with disease status, being highest among patients with progressing KS, intermediate among patients with stable KS, and lowest among patients with regressing KS. Consistent with our previous report high antibody titers to HHV-8 orf 65 were inversely associated with HHV-8 shedding in oral fluid.
Conclusions: We observed a significant association between changes in KS disease severity and the presence and viral load of HHV-8. HHV-8 viral load in blood may provide useful information to clinicians for assessment of the risk of further disease progression in patients with KS.
Comment in
-
Tumor markers and treatments for Kaposi sarcoma.AIDS. 2007 Jul 31;21(12):1637-9. doi: 10.1097/QAD.0b013e32826fb721. AIDS. 2007. PMID: 17630560 No abstract available.
Similar articles
-
Retrospective, longitudinal analysis of serum human herpesvirus-8 viral DNA load in AIDS-related Kaposi's sarcoma patients before and after diagnosis.J Med Virol. 2004 Nov;74(3):390-6. doi: 10.1002/jmv.20192. J Med Virol. 2004. PMID: 15368522
-
Kaposi's sarcoma herpesvirus load in biopsies of cutaneous and oral Kaposi's sarcoma lesions.Eur J Cancer. 2007 Aug;43(12):1877-82. doi: 10.1016/j.ejca.2007.05.023. Epub 2007 Jul 12. Eur J Cancer. 2007. PMID: 17627810
-
Interaction of human immunodeficiency virus type 1 and human herpesvirus type 8 infections on the incidence of Kaposi's sarcoma.J Infect Dis. 2000 Jun;181(6):1940-9. doi: 10.1086/315503. Epub 2000 May 26. J Infect Dis. 2000. PMID: 10837173
-
The role of HHV-8 in Kaposi's sarcoma.Semin Cancer Biol. 1999 Jun;9(3):151-64. doi: 10.1006/scbi.1999.0129. Semin Cancer Biol. 1999. PMID: 10343067 Review.
-
Human herpesvirus 8 and Kaposi's sarcoma in persons infected with human immunodeficiency virus.Clin Infect Dis. 2000 Apr;30 Suppl 1:S72-6. doi: 10.1086/313841. Clin Infect Dis. 2000. PMID: 10770915 Review.
Cited by
-
Reconstitution of immune responses against Kaposi sarcoma-associated herpesvirus.AIDS. 2010 Sep 10;24(14):2279-81. doi: 10.1097/QAD.0b013e32833c7bb8. AIDS. 2010. PMID: 20616696 Free PMC article. No abstract available.
-
Usefulness of Kaposi's Sarcoma-Associated Herpesvirus (KSHV) DNA Viral Load in Whole Blood for Diagnosis and Monitoring of KSHV-Associated Diseases.J Clin Microbiol. 2018 May 25;56(6):e00569-18. doi: 10.1128/JCM.00569-18. Print 2018 Jun. J Clin Microbiol. 2018. PMID: 29643199 Free PMC article. No abstract available.
-
Rapid regression of Kaposi's sarcoma of the hard palate under therapy with boosted elvitegravir-containing fixdose antiretroviral combination therapy.Infection. 2016 Feb;44(1):103-6. doi: 10.1007/s15010-015-0792-8. Epub 2015 May 7. Infection. 2016. PMID: 25947417
-
Donor-derived human herpesvirus 8 and development of Kaposi sarcoma among 6 recipients of organs from donors with high-risk sexual and substance use behavior.Am J Transplant. 2021 Feb;21(2):681-688. doi: 10.1111/ajt.16181. Epub 2020 Aug 4. Am J Transplant. 2021. PMID: 32633035 Free PMC article.
-
Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.Pediatr Infect Dis J. 2013 Nov;32 Suppl 2(0 2):i-KK4. doi: 10.1097/01.inf.0000437856.09540.11. Pediatr Infect Dis J. 2013. PMID: 24569199 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical